×
About 4,702 results

ALLMedicine™ Bacterial Vaginosis Center

Research & Reviews  2,149 results

Identifying Risk Factors for Lower Reproductive Tract Infections among Women Using Reus...
https://doi.org/10.3390/ijerph18094778
International Journal of Environmental Research and Publi... Das P, Lisnek D et. al.

May 5th, 2021 - A large proportion of women in Odisha, India, use reusable absorbents to manage their menstruation. Yet, the risk factors for lower reproductive tract infections (RTIs) related to menstrual hygiene management (MHM) have not been studied among reus...

Clinical comparative study of optimized metronidazole loaded lipid nanocarrier vaginal ...
https://doi.org/10.1080/10717544.2021.1912211
Drug Delivery; Badawi NM, Elkafrawy MA et. al.

Apr 26th, 2021 - The main focus of the current work was to design, evaluate and clinically compare the efficiency of novel metronidazole (MTD) loaded solid lipid nanoparticles (SLNs) vaginal emulgel with the marketed vaginal gel (Metron®) against Bacterial vaginos...

Vaginal sialoglycan foraging by Gardnerella vaginalis: Mucus barriers as a meal for unw...
https://doi.org/10.1093/glycob/cwab024
Glycobiology Agarwal K, Lewis AL

Apr 7th, 2021 - Bacterial vaginosis (BV) is a condition of the vaginal microbiome in which there are few lactobacilli and abundant anaerobic bacteria. Members of the genus Gardnerella are often one of the most abundant bacteria in BV. BV is associated with a wide...

Astodrimer gel for treatment of bacterial vaginosis: A systematic review and meta-analy...
https://doi.org/10.1111/ijcp.14165
International Journal of Clinical Practice; Abu-Zaid A, Alshahrani MS et. al.

Mar 22nd, 2021 - Bacterial vaginosis is a frequent source of vaginal infection among reproductive-aged women. Astodrimer gel is a novel drug which demonstrated favourable outcomes for treatment of patients with bacterial vaginosis. We attempted to conduct a system...

Current and emerging pharmacotherapy for recurrent bacterial vaginosis.
https://doi.org/10.1080/14656566.2021.1904890
Expert Opinion on Pharmacotherapy; Sobel JD, Sobel R

Mar 22nd, 2021 - Given the frequency of recurrent bacterial vaginosis (RBV), enhancing treatment and preventing recurrence have become the central target of pharmacotherapy today. Antimicrobial failure is occurring at a time when knowledge of pathogenesis of bacte...

see more →

Guidelines  13 results

Screening for Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: US P...
https://doi.org/10.1001/jama.2020.2684
JAMA , Owens DK et. al.

Apr 7th, 2020 - Bacterial vaginosis is common and is caused by a disruption of the microbiological environment in the lower genital tract. In the US, reported prevalence of bacterial vaginosis among pregnant women ranges from 5.8% to 19.3% and is higher in some r...

No. 211-Screening and Management of Bacterial Vaginosis in Pregnancy.
https://doi.org/10.1016/j.jogc.2017.04.018
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Yudin MH, Money DM

Jul 21st, 2017 - To review the evidence and provide recommendations on screening for and management of bacterial vaginosis in pregnancy. The clinical practice options considered in formulating the guideline. Outcomes evaluated include antibiotic treatment efficacy...

Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasi...
https://doi.org/10.1016/S1701-2163(15)30316-9
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... van Schalkwyk J, Yudin MH et. al.

May 23rd, 2015 - To review the evidence and provide recommendations on screening for and management of vulvovaginal candidiasis, trichomoniasis, and bacterial vaginosis. OUTCOMES evaluated include the efficacy of antibiotic treatment, cure rates for simple and com...

see more →

Drugs  75 results see all →

Clinicaltrials.gov  2,301 results

Identifying Risk Factors for Lower Reproductive Tract Infections among Women Using Reus...
https://doi.org/10.3390/ijerph18094778
International Journal of Environmental Research and Publi... Das P, Lisnek D et. al.

May 5th, 2021 - A large proportion of women in Odisha, India, use reusable absorbents to manage their menstruation. Yet, the risk factors for lower reproductive tract infections (RTIs) related to menstrual hygiene management (MHM) have not been studied among reus...

Clinical comparative study of optimized metronidazole loaded lipid nanocarrier vaginal ...
https://doi.org/10.1080/10717544.2021.1912211
Drug Delivery; Badawi NM, Elkafrawy MA et. al.

Apr 26th, 2021 - The main focus of the current work was to design, evaluate and clinically compare the efficiency of novel metronidazole (MTD) loaded solid lipid nanoparticles (SLNs) vaginal emulgel with the marketed vaginal gel (Metron®) against Bacterial vaginos...

Vaginal sialoglycan foraging by Gardnerella vaginalis: Mucus barriers as a meal for unw...
https://doi.org/10.1093/glycob/cwab024
Glycobiology Agarwal K, Lewis AL

Apr 7th, 2021 - Bacterial vaginosis (BV) is a condition of the vaginal microbiome in which there are few lactobacilli and abundant anaerobic bacteria. Members of the genus Gardnerella are often one of the most abundant bacteria in BV. BV is associated with a wide...

Nuvessa - metronidazole gel-Exeltis USA, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3b6ff39d-f84b-43b3-9b07-c0521c6d7968

Apr 7th, 2021 - NUVESSA is indicated for the treatment of bacterial vaginosis in females 12 years of age and older. NUVESSA™ is a nitroimidazole antimicrobial indicated for the treatment of bacterial vaginosis in females 12 years of age and older. (1)

Astodrimer gel for treatment of bacterial vaginosis: A systematic review and meta-analy...
https://doi.org/10.1111/ijcp.14165
International Journal of Clinical Practice; Abu-Zaid A, Alshahrani MS et. al.

Mar 22nd, 2021 - Bacterial vaginosis is a frequent source of vaginal infection among reproductive-aged women. Astodrimer gel is a novel drug which demonstrated favourable outcomes for treatment of patients with bacterial vaginosis. We attempted to conduct a system...

see more →

News  147 results

Vaginal Microbiota Can Affect HIV PrEP Drug Metabolism
https://www.medscape.com/viewarticle/943221

Dec 28th, 2020 - NEW YORK (Reuters Health) - Vaginal microbes associated with bacterial vaginosis (BV) metabolize drugs used in HIV pre-exposure prophylaxis (PrEP) at different rates, which could explain why PrEP is less effective in women than in men, new finding...

Consider Switching Up Treatment Regimens for Recurrent Bacterial Vaginosis
https://www.staging.medscape.com/viewarticle/938232

Sep 28th, 2020 - Limited data are available to guide treatment of recurrent bacterial vaginosis, but behavioral changes and switching between approved medication regimens may help, according to a presenter at the virtual conference on diseases of the vulva and vag...

Consider Switching Up Treatment Regimens for Recurrent Bacterial Vaginosis
https://www.medscape.com/viewarticle/938232

Sep 28th, 2020 - Limited data are available to guide treatment of recurrent bacterial vaginosis, but behavioral changes and switching between approved medication regimens may help, according to a presenter at the virtual conference on diseases of the vulva and vag...

Vaginal artesunate quells CIN 2/3 lesions, clears HPV
https://www.mdedge.com/obgyn/article/219749/gynecologic-cancer/vaginal-artesunate-quells-cin-2/3-lesions-clears-hpv/page/0/1?channel=53

Mar 29th, 2020 - Safety and next steps The safety analysis showed that side effects were generally mild and well tolerated. There were 161 adverse events among 29 women for whom safety data were available.

Jury Still Out on BV Screening in Pregnancy for At-Risk Women
https://www.medpagetoday.com/obgyn/pregnancy/82631

Oct 8th, 2019 - Insufficient evidence exists to recommend routine screening for pregnant women at higher risk of preterm birth for bacterial vaginosis, the U.S. Preventive Services Task Force (USPSTF) said. There was not enough evidence to determine the benefits ...

see more →

Patient Education  17 results see all →